SPECTRUM OF BRAF MUTATIONS IN PAKISTANI COHORT
Published in Cancer and Biomedical Research
Colorectal cancer remains a major cause of cancer-related morbidity and mortality worldwide, yet genomic profiling and personalized oncology are far from being a clinical reality in many underdeveloped countries. Our motivation stemmed from a deep concern over this disparity. Despite a growing burden of colorectal cancer in our region, there was a notable absence of local molecular data, particularly regarding actionable mutations such as KRAS and BRAF, which guide prognosis and therapy.
We aimed to generate baseline genomic data regarding BRAF mutations for our local population and identify associated molecular events. Genetic testing services in our country are accessible only to a privileged few, and targeted therapy options are virtually non-existent in public-sector hospitals. This reality adds urgency to our efforts, as the lack of infrastructure perpetuates a cycle of late diagnosis, suboptimal treatment, and poor outcomes.
We hope our work not only contributes to colorectal cancer research but also highlights the need for greater investment in molecular oncology infrastructure in under-resourced settings.
Follow the Topic
-
BMC Cancer
This is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers.
Related Collections
With Collections, you can get published faster and increase your visibility.
Neoadjuvant and adjuvant therapy for gynecologic malignancies
The ongoing research in this field is vital, as it contributes to improving treatment protocols and patient quality of life. Recent breakthroughs have highlighted the significance of personalized treatment approaches, such as targeted therapies and immunotherapies, which have shown promising results in clinical trials. By exploring the optimal sequencing of neoadjuvant and adjuvant therapies, researchers can provide insights into downstaging tumors, minimizing toxicity, and maximizing the overall effectiveness of treatments, leading to better patient outcomes.
Continued exploration and innovation in neoadjuvant and adjuvant therapies hold the potential to transform the management of gynecologic malignancies. Future research may focus on refining treatment regimens, identifying biomarkers for response, and integrating multidisciplinary approaches to optimize surgical and therapeutic outcomes. As we deepen our understanding of tumor heterogeneity and resistance mechanisms, new therapeutic strategies may emerge, offering hope for improved prognosis in patients with these challenging cancers.
- Efficacy of neoadjuvant and adjuvant chemotherapy
- Role of radiation therapy in treatment protocols
- Impact of neoadjuvant vs. adjuvant approaches on fertility and quality of life
- Strategies for downstaging tumors
- Integration of novel therapies in surgical planning
- Resistance mechanisms and strategies for overcoming them
- Role of molecular profiling in guiding therapy
- Clinical trials landscape and future directions
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jul 21, 2026
Prehabilitation in cancer
Prehabilitation in cancer care is an emerging field focused on optimizing patients' physical and psychological well-being prior to undergoing surgery or treatment. By incorporating strategies such as exercise, nutritional support, and psychological interventions, prehabilitation aims to enhance patients’ resilience and overall health outcomes. The concept has gained traction as healthcare professionals recognize the significance of preparing patients for the demands of cancer treatment and recovery, ultimately aiming to improve surgical outcomes and quality of life.
The importance of integrating prehabilitation into cancer care has been underscored by recent advances in research demonstrating its potential benefits. Studies have shown that tailored exercise programs and nutritional interventions can significantly improve treatment outcomes, reduce complications, and enhance recovery times. As healthcare systems increasingly prioritize patient-centered approaches, the implementation of prehabilitation practices may lead to more effective cancer management and improve the overall experience for patients navigating their cancer journey.
Continued research in this area has the potential to revolutionize cancer care practices, paving the way for the development of standardized prehabilitation protocols tailored to individual patient needs. This research may also inspire innovations in telehealth and digital health solutions that facilitate remote prehabilitation interventions, making these essential services more accessible to patients regardless of their geographical location.
Topics welcome to this Collection include, but are not limited to, the following:
- Impact of prehabilitation on surgical outcomes
- Exercise interventions in cancer care
- Nutritional support during prehabilitation
- Prehabilitation and chemotherapy outcomes
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Jan 20, 2027
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in